HomeHOSPITALSNational Jewish Health and Saint Joseph Hospital Launch a Robotic Bronchoscopy Program

National Jewish Health and Saint Joseph Hospital Launch a Robotic Bronchoscopy Program

January 15, 2021

National Jewish Health* and Saint Joseph Hospital** are among the first hospitals in the Rocky Mountain region to have minimally invasive robotic technology that enables physicians to obtain tissue samples from deep within the lung where 70 percent of nodules reside.

“It’s exciting to be able to offer patients with lung nodules an alternative to surgical biopsy,” said Ellen Volker, MD, MSPH, Director of Interventional Pulmonology at National Jewish Health and interventional pulmonologist at Saint Joseph Hospital. “Robotic bronchoscopy allows us to reach more types of lung nodules throughout the entirety of the lung, in one minimally invasive outpatient procedure.”

Dr. Volker explained that National Jewish Health and Saint Joseph Hospital are among the first in the U.S. to combine cone-beam CT technology with robotic bronchoscopy technology. Cone-beam CT allows the doctor to be even more accurate and precise while performing the lung biopsy.

“Our success rate in reaching and successfully obtaining a tissue sample from difficult-to-reach areas of the lung with robotic bronchoscopy and cone-beam CT is greater than 90 percent. Older technologies like electromagnetic navigation bronchoscopy had a success rate of only around 50 percent,” explained Dr. Volker. “This new technology is very good news for lung nodule patients, especially those who may have lung cancer.”

Lung cancer continues to be the leading cause of cancer-related death in men and women. Early detection of lung cancer is one of the best ways to have a successful outcome, but early-stage lung cancers tend to be small and difficult to reach. Robotic bronchoscopy allows physicians to diagnose and stage lung cancer in one minimally invasive procedure, rather than multiple procedures.

“As with all cancers, the sooner we can diagnose and stage lung cancer, the better the outcomes for the patients,” said Dr. Volker.

*National Jewish Health is the leading respiratory hospital in the nation. Founded 122 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune, and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

**SCL Saint Joseph Hospital founded in Denver in 1873 by the Sisters of Charity Leavenworth was the first private hospital in Colorado. Today it is recognized as one of the top hospitals in the nation and largest private teaching hospital in Denver. Specializing in a variety of areas including advanced heart care, pregnancy and childbirth and cancer treatment, Saint Joseph Hospital continues to offer the high-quality, affordable health care that has served Denver for more than 140 years. By working closely with top physicians, Kaiser Permanente and National Jewish Health, the leading respiratory hospital in the nation, Saint Joe’s is able to provide some of the best inpatient and outpatient care in Colorado. Saint Joseph Hospital is part of SCL Health.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy